Sigilon Therapeutics, Inc. Collaboration Agreements
2 Contracts & Agreements
- First Amendment to Research Collaboration and Exclusive License Agreement by and among Sigilon Therapeutics, Inc. and Eli Lilly and Company, dated May 5, 2022 (Filed With SEC on August 4, 2022)
- Research Collaboration and Exclusive License Agreement, by and between Sigilon Therapeutics, Inc. and Eli Lilly and Company, dated April 2, 2018 (Filed With SEC on November 13, 2020)
